Ken Fisher (Trades, Portfolio) is CEO and Co-CIO of Fisher Investments. His investment philosophy is based on the idea that supply and demand of securities is the sole determinate of pricing. Furthermore, he believes that all widely known information has already been priced into the market. Thanks to this, he has about 200 stocks that are giving him a positive return year to date. The following are five with a market cap of at least $10 billion.
He holds 2,490,542 shares of Amazon.com Inc. (AMZN) that has returned 83.90% year-to-date. The stake represents 0.53% of outstanding shares of the company and 2.17% of Fisher’s total assets.
The stock is trading with a forward P/E ratio of 95.24; in the last 12 months the price has risen by 86%, and is now 1.69% below its 52-week high and 100.97% above its 52-week low. It looks overpriced at the current price of $570.76, as the Peter Lynch earnings line gives a fair value of $7.60.
For the second quarter, the company reported an increase of 69% in operating cash flow. Net sales increased by 20% compared to the second quarter of 2014. During this quarter, Amazon launched Prime free same-day delivery in 14 U.S. metro areas, serving more than 500 cities and towns.
GuruFocus gives Amazon a profitability and growth rating of 6 out of 10 with negative returns (ROE -1.73%, ROA -0.40%) that are underperforming 79% of the companies in the Global Specialty Retail industry. Financial strength has a rating of 6 out of 10, with a cash to debt of 1.70 that is above the industry median of 0.90.
Chris Davis (Trades, Portfolio) is the main guru shareholder of the company with 0.96% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) and Jeremy Grantham (Trades, Portfolio) with 0.53%.
Fisher holds 3,238,905 shares of Ctrip.com International Ltd (CTRP) that has returned 56.10% year-to-date. The stake represents 2.28% of outstanding shares of the company and 0.47% of his total assets.
The stock is trading with a forward P/E ratio of 32.36; in the last 12 months the price has risen by 29%, and is now 18.91% below its 52-week high and 74.40% above its 52-week low. It looks overpriced at the current price of $71.05 because the Peter Lynch earnings line gives a fair value of $7.30.
Net revenue grew 47% year-over-year, while total revenues for the second quarter of 2015 increased by 9% from the previous quarter. CTRP reported net commission earned (non-GAAP) with 45% increase year-over-year. Operating margin was 2% for the second quarter of 2015, compared to 5% in the same quarter of a year before.
GuruFocus gives CTRP a profitability and growth rating of 6 out of 10 with weak returns (ROE 0.13%, ROA 0.04%) that are underperforming 69% of the companies in the Global Lodging industry. Financial strength has a rating of 4 out of 10, with a cash to debt of 0.86 that is above the industry median of 0.77.
Andreas Halvorsen (Trades, Portfolio) is the main guru shareholder with 2.28% of outstanding shares, followed by Fisher with 2.28% and Jim Simons (Trades, Portfolio) with 0.24%.
Fisher also holds 13,695 shares of Incyte Corp. (INCY) that has returned 47.40% year-to-date. The stake represents 0.01% of outstanding shares of the company and 0.01% of his total assets.
The stock is trading with a very high P/E ratio of 2033.60; in the last 12 months the price has risen by 112%, and is now 19.34% below its 52-week high and 116.64% above its 52-week low. It looks overpriced at the current price of $107.78. The DCF calculator gives a fair value of $0.44, estimating the stock is overpriced by 24395%.The Peter Lynch earnings line gives a fair value of $0.5.
INCY has a profitability and growth rating of 6 out of 10 with positive return (ROA 1.63%) that is outperforming 78% of the companies in the Global Biotechnology industry. Financial strength has a rating of 7 out of 10, with a cash to debt of 0.95 that is below the industry median of 71.54.
Vanguard Health Care Fund (Trades, Portfolio) is the main guru shareholder with 5.21% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.15% and Joel Greenblatt (Trades, Portfolio) with 0.01%.
Fisher holds a small stake of 5,960 shares of Under Armour Inc. (UA), which has returned 47.40% year-to-date.
The stock is trading with a P/E ratio of 108.80; in the last 12 months the price has risen by 54%, and is now 5.49% below its 52-week high and 61.89% above its 52-week low. It looks overpriced at the current price of $100.08. The DCF calculator gives a fair value of $26.19, estimating the stock is overpriced by 282%.The Peter Lynch earnings line gives a fair value of $13.90.
GuruFocus gives Under Armour a profitability and growth rating of 7 out of 10 with good returns (ROE 15.53%, ROA 9.04%) that are outperforming 74% of the companies in the Global Apparel Manufacturing industry. Financial strength has a rating of 7 out of 10, with a cash to debt of 0.24 that is below the industry median of 1.20.
The main guru shareholder is Ron Baron (Trades, Portfolio) with 2.49% of outstanding shares, followed by Jeremy Grantham (Trades, Portfolio) with 0.02% and Murray Stahl (Trades, Portfolio) with 0.01%.
Fisher holds a small stake of 14,334 shares of Starbucks Corp. (SBUX) that has returned 47.30% year-to-date.
The stock is trading with a P/E ratio of 33.70; in the last 12 months the price has risen by 60%, and is now 1.58% below its 52-week high and 64.46% above its 52-week low. It looks overpriced at the current price of $59.93. The DCF calculator gives a fair value of $26.26, estimating the stock is overpriced by 128%.The Peter Lynch earnings line gives a fair value of $26.2.
Global comparable store sales increased by 7% and consolidated net revenues increased by 18% over Q3 2014, which was driven by incremental revenues from the acquisition of Starbucks Japan.
GuruFocus gives Starbucks a profitability and growth rating of 8 out of 10 with strong returns (ROE 48.11%, ROA 22.99%) that are outperforming 94% of the companies in the Global Restaurants industry. Financial strength has a rating of 8 out of 10, with a cash to debt of 0.75 that is above the industry median of 0.69.
Pioneer Investments (Trades, Portfolio) is the main guru shareholder with 0.34% of outstanding shares.Ă‚
Fisher also holds 128,300 shares of Hologic Inc. (HOLX) that has returned 41.50% year-to-date. The stake represents 0.05% of outstanding shares of the company and 0.01% of his total assets.
The stock is trading with a P/E ratio of 81.00; in the last 12 months the price has risen by 58%, and is now 11.98% below its 52-week high and 63.43% above its 52-week low. It looks overpriced at the current price of $37.85. The DCF calculator gives a fair value of $6.93, estimating the stock is overpriced by 446%.The Peter Lynch earnings line gives a fair value of $6.6.
For the second quarter, the company posted strong organic revenue growth across the board in which revenue grew by 4.9% on a reported basis, and 7.2% on a constant currency basis.
GuruFocus gives Hologic a profitability and growth rating of 7 out of 10 with good returns (ROE 6.34%) that are outperforming 52% of the companies in the Global Medical Instruments & Supplies industry. Financial strength has a rating of 6 out of 10, with a cash to debt of 0.22 that is below the industry median of 1.42.
Carl Icahn is the main guru shareholder with a stake of 12.12% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.62% and Kahn Brothers (Trades, Portfolio) with 0.48%.
